A Pilot Study of Chemoradiotherapy Plus Temsirolimus (Torisel) for Advanced Head and Neck Cancer.

Trial Profile

A Pilot Study of Chemoradiotherapy Plus Temsirolimus (Torisel) for Advanced Head and Neck Cancer.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 25 Oct 2016

At a glance

  • Drugs Cetuximab; Cisplatin; Temsirolimus
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Feb 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 04 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top